Compounds > 1-(indol-4-yloxy)-3-(1-(4-azido-3-iodophenyl)-2-isobutylamine)-2-propanol
Page last updated: 2024-09-03

1-(indol-4-yloxy)-3-(1-(4-azido-3-iodophenyl)-2-isobutylamine)-2-propanol and diazomethane

1-(indol-4-yloxy)-3-(1-(4-azido-3-iodophenyl)-2-isobutylamine)-2-propanol has been researched along with diazomethane in 1 studies

Compound Research Comparison

Studies
(1-(indol-4-yloxy)-3-(1-(4-azido-3-iodophenyl)-2-isobutylamine)-2-propanol)		Trials
(1-(indol-4-yloxy)-3-(1-(4-azido-3-iodophenyl)-2-isobutylamine)-2-propanol)		Recent Studies (post-2010)
(1-(indol-4-yloxy)-3-(1-(4-azido-3-iodophenyl)-2-isobutylamine)-2-propanol)		Studies
(diazomethane)		Trials
(diazomethane)		Recent Studies (post-2010) (diazomethane)
9007010204

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ross, EM; Ruoho, AE; Slaughter, C; Wong, SK1

Other Studies

1 other study(ies) available for 1-(indol-4-yloxy)-3-(1-(4-azido-3-iodophenyl)-2-isobutylamine)-2-propanol and diazomethane

ArticleYear
The catecholamine binding site of the beta-adrenergic receptor is formed by juxtaposed membrane-spanning domains.
    The Journal of biological chemistry, 1988, Jun-15, Volume: 263, Issue:17

    Topics: Affinity Labels; Animals; Azides; Binding Sites; Catecholamines; Cell Membrane; Diazomethane; Iodocyanopindolol; Peptide Mapping; Photochemistry; Pindolol; Receptors, Adrenergic, beta; Rhodopsin; Turkeys

1988